301 related articles for article (PubMed ID: 21677329)
1. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
Van Wagner LB; Koppe SW; Brunt EM; Gottstein J; Gardikiotes K; Green RM; Rinella ME
Ann Hepatol; 2011; 10(3):277-86. PubMed ID: 21677329
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.
Zein CO; Yerian LM; Gogate P; Lopez R; Kirwan JP; Feldstein AE; McCullough AJ
Hepatology; 2011 Nov; 54(5):1610-9. PubMed ID: 21748765
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
Fouda A; Abdelaziz AE; Hussien M; Ali AA; Abdelkawy KS; Elbarbry F
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7449-7459. PubMed ID: 34919247
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet.
Yalniz M; Bahçecioğlu IH; Kuzu N; Celebi S; Ataseven H; Ustündağ B; Ozercan IH; Sahin K
Dig Dis Sci; 2007 Sep; 52(9):2380-6. PubMed ID: 17415655
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.
Zein CO; Lopez R; Fu X; Kirwan JP; Yerian LM; McCullough AJ; Hazen SL; Feldstein AE
Hepatology; 2012 Oct; 56(4):1291-9. PubMed ID: 22505276
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
Koppe SW; Sahai A; Malladi P; Whitington PF; Green RM
J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression.
Wu J; Zhao MY; Zheng H; Zhang H; Jiang Y
Acta Pharmacol Sin; 2010 Oct; 31(10):1367-75. PubMed ID: 20835270
[TBL] [Abstract][Full Text] [Related]
10. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
[TBL] [Abstract][Full Text] [Related]
11. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
[TBL] [Abstract][Full Text] [Related]
12. Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study.
Chande N; Laidlaw M; Adams P; Marotta P
Dig Dis Sci; 2006 Jul; 51(7):1183-9. PubMed ID: 16944007
[TBL] [Abstract][Full Text] [Related]
13. Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial.
Wong VW; Wong GL; Chan AW; Chu WC; Choi PC; Chim AM; Yiu KK; Yu J; Chan FK; Chan HL
J Gastroenterol Hepatol; 2013 Jan; 28(1):57-62. PubMed ID: 23034128
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis.
Vial P; Riquelme A; Pizarro M; Solís N; Madariaga JA; Aguayo G; Duarte I; Soza A; Accatino L; Arrese M
Ann Hepatol; 2006; 5(1):25-9. PubMed ID: 16531961
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study.
Kedarisetty CK; Bhardwaj A; Kumar G; Rastogi A; Bihari C; Kumar M; Sarin SK
Indian J Gastroenterol; 2021 Feb; 40(1):41-49. PubMed ID: 33772456
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.
Sharma BC; Kumar A; Garg V; Reddy RS; Sakhuja P; Sarin SK
J Clin Exp Hepatol; 2012 Dec; 2(4):333-7. PubMed ID: 25755455
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran.
Baniasadi N; Salajegheh F; Pardakhty A; Seyedmirzaee SM; Hayatbakhsh MM; Nikpoor AR; Mohammadi M
Hepat Mon; 2015 Nov; 15(11):e32418. PubMed ID: 26834792
[TBL] [Abstract][Full Text] [Related]
19. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of MK615 for the treatment of patients with liver disorders.
Hokari A; Ishikawa T; Tajiri H; Matsuda T; Ishii O; Matsumoto N; Okuse C; Takahashi H; Kurihara T; Kawahara K; Maruyama I; Zeniya M
World J Gastroenterol; 2012 Aug; 18(31):4118-26. PubMed ID: 22919243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
